This is a preprint.
Comprehensive in-vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms
- PMID: 32676598
- PMCID: PMC7359520
- DOI: 10.1101/2020.07.10.197079
Comprehensive in-vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms
Update in
-
Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.Mol Cell. 2021 Feb 4;81(3):584-598.e5. doi: 10.1016/j.molcel.2020.12.041. Epub 2021 Jan 1. Mol Cell. 2021. PMID: 33444546 Free PMC article.
Abstract
SARS-CoV-2 is the positive-sense RNA virus that causes COVID-19, a disease that has triggered a major human health and economic crisis. The genome of SARS-CoV-2 is unique among viral RNAs in its vast potential to form stable RNA structures and yet, as much as 97% of its 30 kilobases have not been structurally explored in the context of a viral infection. Our limited knowledge of SARS-CoV-2 genomic architecture is a fundamental limitation to both our mechanistic understanding of coronavirus life cycle and the development of COVID-19 RNA-based therapeutics. Here, we apply a novel long amplicon strategy to determine for the first time the secondary structure of the SARS-CoV-2 RNA genome probed in infected cells. In addition to the conserved structural motifs at the viral termini, we report new structural features like a conformationally flexible programmed ribosomal frameshifting pseudoknot, and a host of novel RNA structures, each of which highlights the importance of studying viral structures in their native genomic context. Our in-depth structural analysis reveals extensive networks of well-folded RNA structures throughout Orf1ab and reveals new aspects of SARS-CoV-2 genome architecture that distinguish it from other single-stranded, positive-sense RNA viruses. Evolutionary analysis of RNA structures in SARS-CoV-2 shows that several features of its genomic structure are conserved across beta coronaviruses and we pinpoint individual regions of well-folded RNA structure that merit downstream functional analysis. The native, complete secondary structure of SAR-CoV-2 presented here is a roadmap that will facilitate focused studies on mechanisms of replication, translation and packaging, and guide the identification of new RNA drug targets against COVID-19.
Conflict of interest statement
Declaration of Interests
A patent application on MarathonRT has been filed by Yale University.
Figures








Similar articles
-
Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms.Mol Cell. 2021 Feb 4;81(3):584-598.e5. doi: 10.1016/j.molcel.2020.12.041. Epub 2021 Jan 1. Mol Cell. 2021. PMID: 33444546 Free PMC article.
-
The global and local distribution of RNA structure throughout the SARS-CoV-2 genome.J Virol. 2021 Mar 1;95(5):e02190-20. doi: 10.1128/JVI.02190-20. Epub 2020 Dec 2. J Virol. 2021. PMID: 33268519 Free PMC article.
-
A Structurally Conserved RNA Element within SARS-CoV-2 ORF1a RNA and S mRNA Regulates Translation in Response to Viral S Protein-Induced Signaling in Human Lung Cells.J Virol. 2022 Jan 26;96(2):e0167821. doi: 10.1128/JVI.01678-21. Epub 2021 Nov 10. J Virol. 2022. PMID: 34757848 Free PMC article.
-
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26. Drug Resist Updat. 2020. PMID: 33132205 Free PMC article. Review.
-
Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies.Biochem Soc Trans. 2021 Feb 26;49(1):341-352. doi: 10.1042/BST20200670. Biochem Soc Trans. 2021. PMID: 33367597 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous